{{Rsnum
|rsid=4646440
|Gene=CYP3A4
|Chromosome=7
|position=99763247
|Orientation=minus
|GMAF=0.1056
|Gene_s=CYP3A4
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 98.5 | 1.5 | 0.0
| HCB | 56.8 | 40.9 | 2.3
| JPT | 54.5 | 45.5 | 0.0
| YRI | 79.4 | 17.5 | 3.2
| ASW | 0.0 | 0.0 | 0.0
| CHB | 56.8 | 40.9 | 2.3
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=21902501
|Title=Genetic polymorphisms in CYP3A4 are associated with withdrawal symptoms and adverse reactions in methadone maintenance patients
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}